Related Experiment Video
Updated: Jun 28, 2025
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
87
Rheumatology: What You May Have Missed in 2023.
1Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada (K.J.).
Annals of Internal Medicine
|April 15, 2024
Summary
Recent rheumatology research offers insights for non-specialists. Key findings cover glucocorticoid risks in rheumatoid arthritis (RA), osteoporosis prevention, methotrexate for osteoarthritis, and new treatments for polymyalgia rheumatica and fibromyalgia.
Area of Science:
- Rheumatology
- Internal Medicine
- Pharmacology
Background:
- Many patients with rheumatologic conditions are managed by non-specialists.
- Staying updated on key rheumatology research is crucial for comprehensive patient care.
Purpose of the Study:
- To summarize significant 2023 rheumatology research findings.
- To provide actionable insights for internists and subspecialists managing rheumatologic conditions.
Main Methods:
- Review of six key studies published in 2023.
- Focus on clinical implications for non-rheumatologists.
Main Results:
- Low-dose glucocorticoid use in rheumatoid arthritis (RA) may have different risk profiles.
- Updated guidelines emphasize fracture risk assessment and treatment for glucocorticoid-induced osteoporosis.
- Methotrexate shows potential for inflammatory hand osteoarthritis.
- Sarilumab may aid in polymyalgia rheumatica relapse during glucocorticoid tapering.
- Sublingual cyclobenzaprine presents potential benefits and risks for fibromyalgia.
- Biosimilars demonstrate therapeutic equivalence to reference biologics in RA treatment.
Conclusions:
- Recent rheumatology literature provides valuable updates for non-specialist clinicians.
- Knowledge of these studies aids in managing common rheumatologic conditions effectively.
